494 related articles for article (PubMed ID: 19914719)
1. Variables influencing antidepressant medication adherence for treating outpatients with depressive disorders.
Lee MS; Lee HY; Kang SG; Yang J; Ahn H; Rhee M; Ko YH; Joe SH; Jung IK; Kim SH
J Affect Disord; 2010 Jun; 123(1-3):216-21. PubMed ID: 19914719
[TBL] [Abstract][Full Text] [Related]
2. Association between quality of life and self-stigma, insight, and adverse effects of medication in patients with depressive disorders.
Yen CF; Chen CC; Lee Y; Tang TC; Ko CH; Yen JY
Depress Anxiety; 2009; 26(11):1033-9. PubMed ID: 19288581
[TBL] [Abstract][Full Text] [Related]
3. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
Mouchabac S; Ferreri M; Cabanac F; Bitton M
Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of self-stigma, insight, and perceived adverse effects of medication for the clinical outcomes in patients with depressive disorders.
Yen CF; Lee Y; Tang TC; Yen JY; Ko CH; Chen CC
J Nerv Ment Dis; 2009 Mar; 197(3):172-7. PubMed ID: 19282683
[TBL] [Abstract][Full Text] [Related]
5. [Relationships between insight and medication adherence in subjects with psychosis].
Droulout T; Liraud F; Verdoux H
Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
[TBL] [Abstract][Full Text] [Related]
6. Working with reactant patients: are we prescribing nonadherence?
Madsen JW; McQuaid JR; Craighead WE
Depress Anxiety; 2009; 26(2):129-34. PubMed ID: 18972363
[TBL] [Abstract][Full Text] [Related]
7. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
Akiskal HS; Benazzi F; Perugi G; Rihmer Z
J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
[TBL] [Abstract][Full Text] [Related]
8. A randomized, controlled trial of duloxetine alone vs. duloxetine plus a telephone intervention in the treatment of depression.
Perahia DG; Quail D; Gandhi P; Walker DJ; Peveler RC
J Affect Disord; 2008 May; 108(1-2):33-41. PubMed ID: 17905442
[TBL] [Abstract][Full Text] [Related]
9. Use of slow-release melatonin in treatment-resistant depression.
Dalton EJ; Rotondi D; Levitan RD; Kennedy SH; Brown GM
J Psychiatry Neurosci; 2000 Jan; 25(1):48-52. PubMed ID: 10721684
[TBL] [Abstract][Full Text] [Related]
10. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression.
Schmidt PJ; Daly RC; Bloch M; Smith MJ; Danaceau MA; St Clair LS; Murphy JH; Haq N; Rubinow DR
Arch Gen Psychiatry; 2005 Feb; 62(2):154-62. PubMed ID: 15699292
[TBL] [Abstract][Full Text] [Related]
11. Knowledge of and attitudes towards depression and adherence to treatment: the Antidepressant Adherence Scale (AAS).
Gabriel A; Violato C
J Affect Disord; 2010 Nov; 126(3):388-94. PubMed ID: 20708273
[TBL] [Abstract][Full Text] [Related]
12. Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project.
Trivedi MH; Rush AJ; Crismon ML; Kashner TM; Toprac MG; Carmody TJ; Key T; Biggs MM; Shores-Wilson K; Witte B; Suppes T; Miller AL; Altshuler KZ; Shon SP
Arch Gen Psychiatry; 2004 Jul; 61(7):669-80. PubMed ID: 15237079
[TBL] [Abstract][Full Text] [Related]
13. Patient-rated troubling symptoms of depression instrument results correlate with traditional clinician- and patient-rated measures: a secondary analysis of a randomized, double-blind, placebo-controlled trial.
Pandina GJ; Revicki DA; Kleinman L; Turkoz I; Wu JH; Kujawa MJ; Mahmoud R; Gharabawi GM
J Affect Disord; 2009 Nov; 118(1-3):139-46. PubMed ID: 19321206
[TBL] [Abstract][Full Text] [Related]
14. Adaptation of dialectical behavior therapy skills training group for treatment-resistant depression.
Harley R; Sprich S; Safren S; Jacobo M; Fava M
J Nerv Ment Dis; 2008 Feb; 196(2):136-43. PubMed ID: 18277222
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
[TBL] [Abstract][Full Text] [Related]
16. Predictors of treatment response for depression and inadequate social support--the ENRICHD randomized clinical trial.
Cowan MJ; Freedland KE; Burg MM; Saab PG; Youngblood ME; Cornell CE; Powell LH; Czajkowski SM;
Psychother Psychosom; 2008; 77(1):27-37. PubMed ID: 18087205
[TBL] [Abstract][Full Text] [Related]
17. Just keep taking the tablets: adherence to antidepressant treatment in older people in primary care.
Maidment R; Livingston G; Katona C
Int J Geriatr Psychiatry; 2002 Aug; 17(8):752-7. PubMed ID: 12211126
[TBL] [Abstract][Full Text] [Related]
18. Symptoms of anxiety in depression: assessment of item performance of the Hamilton Anxiety Rating Scale in patients with depression.
Vaccarino AL; Evans KR; Sills TL; Kalali AH
Depress Anxiety; 2008; 25(12):1006-13. PubMed ID: 18800370
[TBL] [Abstract][Full Text] [Related]
19. Six-month compliance with antidepressant medication in the treatment of major depressive disorder.
Demyttenaere K; Adelin A; Patrick M; Walthère D; Katrien de B; Michèle S
Int Clin Psychopharmacol; 2008 Jan; 23(1):36-42. PubMed ID: 18090506
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder.
Septien-Velez L; Pitrosky B; Padmanabhan SK; Germain JM; Tourian KA
Int Clin Psychopharmacol; 2007 Nov; 22(6):338-47. PubMed ID: 17917552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
